Agilent Technologies, Inc. - Diagnostics and Genomics SS CD GlasgowCancerPlus, 16
The Agilent SureSelect Custom DNA Glasgow Cancer Plus Panel (part number 5191-6950) is designed for targeted next-generation sequencing (NGS) applications in cancer research. This panel enables comprehensive analysis of key cancer-related genes, supporting the detection of somatic mutations in a wide range of cancer types. The kit provides reagents for 16 reactions and is optimized for high specificity and sensitivity, ensuring reliable enrichment of target regions from genomic DNA. The SureSelect platform is compatible with Illumina sequencing systems and integrates seamlessly into existing NGS workflows, facilitating efficient and accurate variant detection for translational and clinical research.